A critical breakthrough in cancer study is arising with the use of mini-antibodies to reactivate mutated p53. This essential malignant inhibitor protein is frequently disabled in many kinds of cancer, leading https://isocialfans.com/story7546630/nanobodies-revive-tumor-suppressor-p53-new-potential-pathway-for-cancer-therapy